"Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity" (COPD_HSRG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01644916|
Recruitment Status : Completed
First Posted : July 19, 2012
Last Update Posted : September 7, 2018
Chronic obstructive pulmonary disease (COPD) stands out among chronic diseases with its high and rising prevalence and mortality, poor quality of life, high re-hospitalization rates and societal burden of care. Current therapeutic and management practices are generally met with limited success. Research in recent years have highlighted the high level of psychiatric co-morbidity in COPD patients, and the major prognostic significance of anxiety/depression in COPD outcomes such as re-hospitalization, smoking cessation, quality of life, and survival. This suggests that addressing psychiatric and psycho-social aspects of care prominent in COPD patients may have strongly positive impact on outcomes, but the available evidence of effectiveness is limited.
The primary aim of the proposed research is to evaluate the effectiveness of a holistic disease management paradigm of psychiatric liaison consultation (CL) that integrates psychiatric and respiratory care to improve outcomes for COPD patients. This integrated psychiatric consultation liaison (IPCL) management paradigm includes the routine screening and structured collaborative care of anxiety and major depressive symptoms and depressive/anxiety disorder in COPD patients. We postulate that the IPCL care paradigm would reduce mood symptoms, increase smoking quit rates, reduce symptom burden and functional disability, and improve quality of life, while reducing rehospitalization, emergency department (ED) and unscheduled physician visits. A secondary aim is to evaluate its cost effectiveness by concurrently collecting resource utilization data.
|Condition or disease||Intervention/treatment||Phase|
|Chronic Obstructive Pulmonary Disease Anxiety Depression||Procedure: Integrated care Procedure: Usual control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||295 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||"Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity"|
|Actual Study Start Date :||August 2012|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 2017|
Usual control will be provided with usual standard management of COPD and psychiatric comorbidities.
Procedure: Usual control
Usual control group will be provided with usual standard procedures for management of COPD and psychiatric comorbidities.
Integrated care will be provided with integrated care management.
Procedure: Integrated care
Integrated care will be provided with management of multifaceted group including, nurse educators, doctors, case manager and psychologists.
Other Name: IPCL
- HADS score [ Time Frame: over 12 months ]Anxiety and depression symptoms and diagnosis
- Resource use and direct costs of care [ Time Frame: over 12 months ]Resource use include inpatient service use (No. of times hospitalized and total days in hospital) , outpatient service use (physician visits consisting of GP visits and specialist visits,) and medication use( usage of any or specific drug classes)and costs for resource use over 12 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01644916
|National University Hospital System|
|Singapore, Singapore, 119228|
|Principal Investigator:||Ng T Pin, MD||National University, Singapore|